Igg-Dependent Hydrolysis of Myelin Basic Protein of Patients with Different Courses of Schizophrenia

Table 4

Characteristics of IgG proteolytic activity levels in patients with different clinical forms of schizophrenia and in healthy control subjects.

Group	Healthy control subjects, mg MBP/mg IgG/h	Patients with remission, mg MBP/mg IgG/h	Continuous course of schizophrenia, mg MBP/mg IgG/h	Episodic course of schizophrenia with progressive deficit, mg MBP/mg IgG/h	Episodic course of schizophrenia with stable deficit, mg MBP/mg IgG/h	Simple schizophrenia, mg MBP/mg IgG/h	value
	24	31	12	12	12	12
Median [Q1-Q4]	0.00[0.00; 0.24]	0.656[0.279; 0.873]	1.810[0.746; 4.101]	0.539[0.00; 4.460]	0.831[0.123; 1.859]	0.630[0309; 2.050]	0.0002

value from multiple comparisons with Kruskal–Wallis test including all groups of patients and healthy control group; significant at <0.05.